• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喜树碱新型非内酯类似物的合成与药理评价

Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.

作者信息

Hautefaye Patrick, Cimetière Bernard, Pierré Alain, Léonce Stéphane, Hickman John, Laine William, Bailly Christian, Lavielle Gilbert

机构信息

Institut de Recherches Servier, 125 Chemin de Ronde, 78290, Croissy sur Seine, France.

出版信息

Bioorg Med Chem Lett. 2003 Aug 18;13(16):2731-5. doi: 10.1016/s0960-894x(03)00534-1.

DOI:10.1016/s0960-894x(03)00534-1
PMID:12873503
Abstract

Ten novel camptothecin (CPT) derivatives devoid of the lactone function in the E-ring were synthesized and evaluated as anticancer agents. Several of these CPT analogues bearing a five-membered E-ring are potent inhibitors of the DNA relaxation and cleavage reactions catalyzed by topoisomerase I and exhibit promising cytotoxic activities with IC(50) values in the nM range. This is the first successful design of lactone-free CPT, providing thus a new avenue to the development of topoisomerase I targeted antitumor agents.

摘要

合成了10种在E环中没有内酯功能的新型喜树碱(CPT)衍生物,并将其作为抗癌剂进行评估。这些带有五元E环的CPT类似物中有几种是拓扑异构酶I催化的DNA松弛和切割反应的有效抑制剂,并表现出有前景的细胞毒性活性,其半数抑制浓度(IC50)值在纳摩尔范围内。这是无内酯CPT的首次成功设计,从而为开发靶向拓扑异构酶I的抗肿瘤药物提供了一条新途径。

相似文献

1
Synthesis and pharmacological evaluation of novel non-lactone analogues of camptothecin.喜树碱新型非内酯类似物的合成与药理评价
Bioorg Med Chem Lett. 2003 Aug 18;13(16):2731-5. doi: 10.1016/s0960-894x(03)00534-1.
2
Homocamptothecin, an E-ring-modified camptothecin analogue, generates new topoisomerase I-mediated DNA breaks.高喜树碱,一种E环修饰的喜树碱类似物,可产生新的拓扑异构酶I介导的DNA断裂。
Biochemistry. 1999 Nov 23;38(47):15556-63. doi: 10.1021/bi990947h.
3
Novel E-ring camptothecin keto analogues (S38809 and S39625) are stable, potent, and selective topoisomerase I inhibitors without being substrates of drug efflux transporters.新型E环喜树碱酮类似物(S38809和S39625)是稳定、强效且具有选择性的拓扑异构酶I抑制剂,并非药物外排转运体的底物。
Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3229-38. doi: 10.1158/1535-7163.MCT-07-0441.
4
Semi-synthesis and biological activity of gamma-lactones analogs of camptothecin.喜树碱γ-内酯类似物的半合成及生物活性
Bioorg Med Chem Lett. 2008 Dec 15;18(24):6441-3. doi: 10.1016/j.bmcl.2008.10.074. Epub 2008 Oct 19.
5
Transport mechanism-based drug molecular design: novel camptothecin analogues to circumvent ABCG2-associated drug resistance of human tumor cells.基于转运机制的药物分子设计:新型喜树碱类似物以规避人肿瘤细胞中ABCG2相关的耐药性
Curr Pharm Des. 2006;12(3):313-25. doi: 10.2174/138161206775201992.
6
Structure-based analysis of the effects of camptothecin on the activities of human topoisomerase I.基于结构的喜树碱对人拓扑异构酶I活性影响的分析
Ann N Y Acad Sci. 2000;922:56-64. doi: 10.1111/j.1749-6632.2000.tb07025.x.
7
Homocamptothecin, an E-ring modified camptothecin with enhanced lactone stability, retains topoisomerase I-targeted activity and antitumor properties.高喜树碱是一种E环修饰的喜树碱,内酯稳定性增强,保留了靶向拓扑异构酶I的活性和抗肿瘤特性。
Cancer Res. 1999 Jun 15;59(12):2939-43.
8
Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.通过酮官能团取代E环内酯得到的新型稳定喜树碱衍生物是拓扑异构酶I的有效抑制剂和有前景的抗肿瘤药物。
Mol Pharmacol. 2007 Aug;72(2):311-9. doi: 10.1124/mol.107.034637. Epub 2007 May 9.
9
Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I.9-苄亚基氨基同型喜树碱衍生物的合成与评价及其对 DNA 拓扑异构酶 I 的抑制活性。
Eur J Med Chem. 2010 Jun;45(6):2223-8. doi: 10.1016/j.ejmech.2010.01.063. Epub 2010 Feb 1.
10
Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors.7-烯丙基同型喜树碱的合成及生物评价作为有效的拓扑异构酶 I 抑制剂。
Chem Biodivers. 2012 Jun;9(6):1084-94. doi: 10.1002/cbdv.201100195.

引用本文的文献

1
DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.DNA拓扑异构酶及其被抗癌和抗菌药物抑制的情况。
Chem Biol. 2010 May 28;17(5):421-33. doi: 10.1016/j.chembiol.2010.04.012.
2
DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.DNA拓扑异构酶I抑制剂:化学、生物学及界面抑制
Chem Rev. 2009 Jul;109(7):2894-902. doi: 10.1021/cr900097c.
3
DNA cleavage assay for the identification of topoisomerase I inhibitors.用于鉴定拓扑异构酶I抑制剂的DNA切割试验
Nat Protoc. 2008;3(11):1736-50. doi: 10.1038/nprot.2008.174.